Ontario study reheats rosiglitazone controversyResearch recommends avoiding the medication due to cardiovascular risks DIABETES: A1c level touted as a better way to diagnose diabetesADA task force to explore implications of study’s recommendations Dealing with 'spoiled' Canadian patients After a medical mission in Honduras, complaints of more privileged patients seem a little harder to bear High-fructose corn syrup not to blame for obesity, diabetes Additive has merely replaced sucrose as a sweetener, so the real problem is the rising total intake of sugars by the population DIABETES: Trial suggests rosiglitazone concerns may be overblown Winner of Prix Galien 2008 Research Award to propose new treatment for intestinal disorders Other new products: September 2009 Spotlight: Doug Clarke The expanded world of pharmacy How far have you come—and how far will you go? Ask the Expert: Diabetes First Previous 217 218 219 220 221 Next Last
